Compare Astraea
Astraea vs. Traditional CRO & In-House Biometrics
Compare sponsor-operated clinical trial automation with outsourced CRO delivery. Astraea covers post-protocol work through submission inside the sponsor's environment. It is software, not a CRO.
The verdict
Astraea is a sponsor-operated clinical trial automation platform, not a CRO. It automates post-protocol work through submission inside the sponsor's environment, and Astraea does not see customer data. Choose Astraea to operate these workflows with your own team. Choose a CRO to transfer defined trial functions to a service provider under a written agreement. Scientific decisions, output approval, and sponsor oversight remain human responsibilities.
Platform workflow · Review and deployment responsibilities · Written transfer of CRO obligations
What does Astraea automate?
Astraea automates SAPs, eCRFs, TFLs, SDTM and ADaM datasets, Define-XML, QC, and submission documents after protocol design and raw data collection. Forward-deployed engineers install the platform inside the sponsor's environment. Sponsors operate the software, and qualified experts retain scientific decisions and output approval.
What changes operationally?
A quick view of where the workflow runs, who operates it, and what capability remains with your team.
| Decision question | Astraea | Traditional CRO | Bottom line |
|---|---|---|---|
| What is being purchased? | Clinical trial automation software with in-environment installation | Delivery of functions specified in a written agreement | Software operation and outsourced trial delivery are different purchases. |
| Where does trial data stay? | Inside the sponsor's environment | Varies by CRO, systems, and contract | Astraea's model keeps customer data away from Astraea. |
| Who operates the workflow? | Sponsor teams operate Astraea software | The CRO performs the functions it assumes under the written agreement | Define execution, review, and oversight responsibilities. |
| How is deployment arranged? | Forward-deployed engineers install Astraea inside the sponsor environment | Systems and access requirements depend on the agreed scope | Confirm access, validation, and operational ownership during evaluation. |
When to choose Traditional CRO
Choose a traditional CRO when the sponsor wants an external organization to assume delivery responsibility for defined trial functions.
When to choose Astraea
Choose Astraea when the sponsor wants to keep execution control and build repeatable internal post-protocol capability.
Map one current workflow before comparing vendors.
Bring one biometrics or submission workflow. Astraea will map where data moves, who owns each handoff, and what could run inside your environment.
Side by side
How Astraea compares to a CRO or in-house team.
CRO and in-house models allocate work, systems, oversight, and accountability differently. Astraea can automate defined biometrics workflows within either operating model without replacing the sponsor's scientific and oversight responsibilities.
| Criterion | Astraea | Traditional CRO | In-House Biometrics |
|---|---|---|---|
| End-to-end pipeline in one system | SAPs, eCRFs, TFLs, SDTM/ADaM, Define-XML, QC, and submission documents | Deliverables and systems depend on the written agreement | Deliverables and systems depend on the internal operating model |
| Timeline model | Automates post-protocol workflow steps; evaluate timing against study scope and readiness | Evaluate timing against the proposed scope and delivery plan | Evaluate timing against internal capacity and the study plan |
| Automation model | Multi-agent AI software with qualified human review | Automation capabilities must be assessed for the selected provider | Automation capabilities depend on the selected systems |
| Human-in-the-loop control | Qualified experts retain scientific interpretation and output approval | The written agreement defines transferred functions and responsibilities | The sponsor defines review and approval responsibilities |
| Auditability & traceability | Outputs connect to code, data, and analysis context for review | Evaluate records, controls, and review evidence for the agreed scope | Evaluate records, controls, and review evidence for internal workflows |
| Standards and submission work | SDTM, ADaM, Define-XML, QC, and submission-document automation; outputs require review | Assess agreed deliverables against the applicable standards and submission requirements | Assess internal deliverables against the applicable standards and submission requirements |
| Therapeutic & indication coverage | Indication expertise across oncology, rare disease, other therapeutics, and devices | Assess the proposed team against the study indication | Assess the internal team against the study indication |
| Cost model | Request a proposal for the workflow and deployment under evaluation | Request a proposal for the functions to be transferred | Estimate the resources and systems required for the same scope |
| Data ownership & control | Runs in the sponsor environment; Astraea does not see customer data | Confirm data access, processing, and custody in the agreement | Confirm data access and custody for the systems in use |
| Deployment / ramp | Installed by forward-deployed engineers inside the sponsor environment | Confirm transition, systems access, and delivery requirements in the agreement | Assess available systems, staff, and validation requirements |
Outsourced delivery
When outsourced delivery fits the operating model.
Transfer defined trial functions
A sponsor can transfer defined trial obligations to a CRO in writing. The agreement must identify the obligations being assumed; responsibilities outside that agreement are not transferred.
Assess the proposed team
Evaluate the proposed CRO team, systems, and evidence against the study indication and the functions in scope. CRO capabilities are provider-specific; this comparison does not establish that any provider is stronger than Astraea in scientific expertise.
Separate delivery from software
A CRO performs the trial functions it assumes under the written agreement. Astraea is software that sponsor teams operate inside their own environment, not a CRO that assumes those functions.
Where Astraea wins
Three reasons teams automate the pipeline with Astraea.
Post-protocol work through submission.
Astraea automates SAPs, eCRFs, TFLs, SDTM and ADaM datasets, Define-XML, QC, and submission documents. Its scope is the connected post-protocol workflow, not biometrics alone.
Sponsor-operated automation.
Sponsor teams operate Astraea software. Qualified statisticians and programmers retain responsibility for reviewing methods, checking outputs, and approving deliverables. Automation supports execution without replacing scientific judgment.
Deployment inside your environment.
Forward-deployed engineers install Astraea inside the sponsor environment. Astraea does not see customer data. Technical evaluation establishes access, operational controls, and validation responsibilities before production use.
FAQ
Astraea vs. CRO, answered.
The questions biometrics and biostatistics leads ask most when weighing automation against a traditional CRO or in-house team.
Is Astraea a CRO, and what does it automate?
No. Astraea is a sponsor-operated clinical trial automation platform, not a CRO. It automates SAPs, eCRFs, TFLs, SDTM/ADaM, Define-XML, QC, and submission documents after protocol design and raw data collection. Engineers install it inside the sponsor's environment; Astraea does not see customer data. Qualified experts retain scientific decisions and output approval.
Is Astraea better than a traditional CRO?
Astraea fits teams that want to operate post-protocol-to-submission automation inside their own environment. A CRO fits sponsors that want to transfer defined trial functions under a written agreement. The choice depends on the functions, responsibilities, and operating model being evaluated, not a universal claim that one is better.
What is the difference between Astraea and a CRO?
A CRO is a service provider contracted to perform one or more sponsor trial functions; the exact scope is defined in writing and may include data management, biostatistics, programming, monitoring, or broader trial operations. Astraea is software the sponsor operates to automate post-protocol biometrics and submission workflows, with human reviewers approving outputs.
Is Astraea cheaper than a CRO?
A reliable cost comparison requires actual proposals for the same scope. Evaluate software deployment, implementation, internal review, and any contracted trial functions together. This page does not establish that Astraea or a CRO is cheaper.
Can Astraea replace my CRO or in-house team?
Astraea can automate defined biometrics and submission workflows, but it is not a like-for-like replacement for every CRO or in-house function. Sponsors still need qualified experts for scientific decisions, oversight, validation, and approvals, and may continue using CROs for transferred operational or specialist responsibilities.
Who should use a traditional CRO instead of Astraea?
Teams that want to transfer defined clinical-development functions—such as monitoring, site operations, data management, safety, or regulatory deliverables—to a service provider should consider a CRO. Astraea is focused on sponsor-operated automation after protocol and raw data and can be used alongside internal experts or contracted service providers.
Evaluate the post-protocol-to-submission workflow.
Bring a representative workflow to a demo. Discuss the inputs, deliverables, review responsibilities, and deployment inside your environment.